chrX-72181798-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006223.4(PIN4):c.13G>A(p.Gly5Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000038 in 1,183,531 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000054 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.000036 ( 0 hom. 22 hem. )
Consequence
PIN4
NM_006223.4 missense
NM_006223.4 missense
Scores
2
7
7
Clinical Significance
Conservation
PhyloP100: 4.06
Genes affected
PIN4 (HGNC:8992): (peptidylprolyl cis/trans isomerase, NIMA-interacting 4) This gene encodes a member of the parvulin subfamily of the peptidyl-prolyl cis/trans isomerase protein family. The encoded protein catalyzes the isomerization of peptidylprolyl bonds, and may play a role in the cell cycle, chromatin remodeling, and/or ribosome biogenesis. The encoded protein may play an additional role in the mitochondria. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.057047695).
BS2
High Hemizygotes in GnomAdExome4 at 22 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIN4 | NM_006223.4 | c.13G>A | p.Gly5Arg | missense_variant | 1/4 | ENST00000373669.8 | NP_006214.3 | |
PIN4 | NM_001170747.1 | c.88G>A | p.Gly30Arg | missense_variant | 1/4 | NP_001164218.1 | ||
PIN4 | NR_033187.2 | n.42G>A | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIN4 | ENST00000373669.8 | c.13G>A | p.Gly5Arg | missense_variant | 1/4 | 1 | NM_006223.4 | ENSP00000362773 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000536 AC: 6AN: 112021Hom.: 0 Cov.: 24 AF XY: 0.0000293 AC XY: 1AN XY: 34183
GnomAD3 genomes
AF:
AC:
6
AN:
112021
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34183
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000575 AC: 10AN: 173899Hom.: 0 AF XY: 0.0000842 AC XY: 5AN XY: 59395
GnomAD3 exomes
AF:
AC:
10
AN:
173899
Hom.:
AF XY:
AC XY:
5
AN XY:
59395
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000364 AC: 39AN: 1071510Hom.: 0 Cov.: 27 AF XY: 0.0000648 AC XY: 22AN XY: 339248
GnomAD4 exome
AF:
AC:
39
AN:
1071510
Hom.:
Cov.:
27
AF XY:
AC XY:
22
AN XY:
339248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000536 AC: 6AN: 112021Hom.: 0 Cov.: 24 AF XY: 0.0000293 AC XY: 1AN XY: 34183
GnomAD4 genome
AF:
AC:
6
AN:
112021
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34183
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.88G>A (p.G30R) alteration is located in exon 1 (coding exon 1) of the PIN4 gene. This alteration results from a G to A substitution at nucleotide position 88, causing the glycine (G) at amino acid position 30 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;T;D
Polyphen
0.99
.;.;D;.
Vest4
MutPred
Gain of solvent accessibility (P = 0.019);Gain of solvent accessibility (P = 0.019);Gain of solvent accessibility (P = 0.019);.;
MVP
MPC
0.57
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at